Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Liposarcoma × eribulin × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 3 Urinary Bladder Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Recurrence 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HER2-low Breast Cancer 1 Carcinoma, Transitional Cell 1 Brest Cancer 1 Brain Neoplasms 1

Interventions

Doxorubicin 4 Specimen Handling 3 pazopanib 2 brigimadlin 2 Radiotherapy 2 Radiation 2 Ifosfamide 2 Biopsy 2 talimogene laherparepvec 1 silmitasertib 1 selinexor 1 pembrolizumab 1 palbociclib 1 mirdametinib 1 abemaciclib 1 X-Rays 1 Vincristine 1 Trabectedin 1 Temozolomide 1 Surgical Procedures, Operative 1 Quality of Life 1 Proton Therapy 1 Pioglitazone 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Gemcitabine 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡